Showing 11,901 - 11,920 results of 134,101 for search '(( a d decrease ) OR ( 5 ((nn decrease) OR (((a decrease) OR (mean decrease)))) ))', query time: 1.93s Refine Results
  1. 11901
  2. 11902
  3. 11903
  4. 11904
  5. 11905
  6. 11906
  7. 11907
  8. 11908

    Surface Interactions and Quantum Kinetic Molecular Sieving for H<sub>2</sub> and D<sub>2</sub> Adsorption on a Mixed Metal−Organic Framework Material by Banglin Chen (1525054)

    Published 2008
    “…The enthalpy of adsorption, decreases with increasing amount adsorbed to 9.5 kJ mol<sup>−1</sup> at ∼1.9 mmol g<sup>−1</sup> (2 H<sub>2</sub> or D<sub>2</sub> molecules per Cu corresponding to adsorption on both sides of planar Cu open centers) and is virtually unchanged in the range 1.9−3.6 mmol g<sup>−1</sup>. …”
  9. 11909

    Inhibition of C5aR signaling and targeted complement inhibition alleviates liver injury. by Shihui Sun (180042)

    Published 2013
    “…<p>(A–I) Both C5aRmAb and CR2-fH groups displayed reduced liver damage (A–B, D–E, G–H) and decreased C3 deposition (C, F, I) 8 hours after LPS/D-GalN injection. …”
  10. 11910

    Confirmation of promoter DNA demethylation with low-dose 5-aza in NT2/D1 cells. by Bijesh K. Biswal (109082)

    Published 2012
    “…<p><b>A</b>, Representative bisulfite pyrosequencing tracing from NT2/D1 cells treated with vehicle control or 10 nM 5-aza for 3 days in the promoter region of SOX15. …”
  11. 11911
  12. 11912
  13. 11913
  14. 11914

    <i>WDR5</i> Expression Is Prognostic of Breast Cancer Outcome by Xiaofeng Dai (793874)

    Published 2015
    “…<div><p>WDR5 is a core component of the human mixed lineage leukemia-2 complex, which plays central roles in ER positive tumour cells and is a major driver of androgen-dependent prostate cancer cell proliferation. …”
  15. 11915
  16. 11916

    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

    Published 2021
    “…Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC<sub>50</sub> = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”
  17. 11917

    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

    Published 2021
    “…Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC<sub>50</sub> = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”
  18. 11918
  19. 11919
  20. 11920

    EPIC Trial: education programme impact on serum phosphorous control in CKD 5D patients on hemodialysis by Carmen Tzanno Branco Martins (4748892)

    Published 2018
    “…<div><p>Abstract Introduction: In stage 5D chronic kidney disease (CKD 5D) patients, the encouragement of treatment adherence by health professionals is a significant clinical challenge. …”